Advertisement
Search:
Advanced Search
ATVB Home
Subscriptions
Archives
Feedback
Authors
Help
AHA Journals Home
« Previous Issue
|
Next Issue »
About This Cover
Volume 28, Issue 10; October 1, 2008
Editorials
Brief Reviews
Integrative Physiology/Experimental Medicine
Cell Biology/Signaling
Clinical and Population Studies
Letters to the Editor
Search This Issue:
Table of Contents (PDF)
Index by Author
Sign up for eTOCs
Key:  
VB = Vascular Biology
  
AL = Atherosclerosis/Lipoproteins
  
TH = Thrombosis
To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.
article is free immediately upon publication
Editorials
Kinetic Studies of the Metabolism of Rapidly Exchangeable Apolipoproteins May Leave Investigators and Readers With Exchangeable Results
Henry N. Ginsberg and Rajasekhar Ramakrishnan
Arterioscler Thromb Vasc Biol. 2008;28:1685-1686, doi:10.1161/ATVBAHA.108.174185
Extract
|
Full Text
|
PDF
Apelin-APJ Signaling in Retinal Angiogenesis
Yoko Kojima and Thomas Quertermous
Arterioscler Thromb Vasc Biol. 2008;28:1687-1688, doi:10.1161/ATVBAHA.108.174847
Extract
|
Full Text
|
PDF
A New Kid on the Block: PKD1: A Promising Target for Antiangiogenic Therapy?
Joachim Altschmied and Judith Haendeler
Arterioscler Thromb Vasc Biol. 2008;28:1689-1690, doi:10.1161/ATVBAHA.108.174250
Extract
|
Full Text
|
PDF
Endothelial H
2
O
2
: A Bad Guy Turning Good?
Wolfgang F. Graier and Markus Hecker
Arterioscler Thromb Vasc Biol. 2008;28:1691-1693, doi:10.1161/ATVBAHA.108.173963
Extract
|
Full Text
|
PDF
Brief Reviews
Death Receptors and Their Ligands in Atherosclerosis
Mary M. Kavurma, Nicole Y. Tan, and Martin R. Bennett
Arterioscler Thromb Vasc Biol. 2008;28:1694-1702; published online before print July 31 2008, doi:10.1161/ATVBAHA.107.155143
Abstract
|
Full Text
|
PDF
On binding to their ligands, death receptors transmit apoptotic signals leading to irreversible programmed cell death. Recent studies also implicate death receptors in survival/activation signals, and consequently their role in atherosclerosis is unclear. This review encapsulates our recent understanding of death receptor signaling in atherosclerosis and related disorders.
Integrins: The Keys to Unlocking Angiogenesis
Rita Silva, Gabriela D'Amico, Kairbaan M. Hodivala-Dilke, and Louise E. Reynolds
Arterioscler Thromb Vasc Biol. 2008;28:1703-1713; published online before print July 24 2008, doi:10.1161/ATVBAHA.108.172015
Abstract
|
Full Text
|
PDF
Integrative Physiology/Experimental Medicine
Brief Report: Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice Lacking the Membrane-Bound Complement Regulator CD59
Sheng Yun, Viola W.Y. Leung, Marina Botto, Joseph J. Boyle, and Dorian O. Haskard
Arterioscler Thromb Vasc Biol. 2008;28:1714-1716; published online before print July 10 2008, doi:10.1161/ATVBAHA.108.169912
Abstract
|
Full Text
|
PDF
|
Data Supplement
Retardation of Retinal Vascular Development in Apelin-Deficient Mice
Atsushi Kasai, Norihito Shintani, Hideaki Kato, Satoshi Matsuda, Fumi Gomi, Ryota Haba, Hitoshi Hashimoto, Michiya Kakuda, Yasuo Tano, and Akemichi Baba
Arterioscler Thromb Vasc Biol. 2008;28:1717-1722; published online before print July 3 2008, doi:10.1161/ATVBAHA.108.163402
Abstract
|
Full Text
|
PDF
|
Data Supplement
To identify the roles of endogenous apelin, we investigated the phenotype of apelin-KO mice. Our results suggest that spatiotemporally regulated apelin/APJ signaling participates in retinal vascularization in a cooperative manner with VEGF or FGF2 and contributes to normal ocular development.
Acid Sphingomyelinase Promotes Lipoprotein Retention Within Early Atheromata and Accelerates Lesion Progression
Cecilia M. Devlin, Andrew R. Leventhal, George Kuriakose, Edward H. Schuchman, Kevin Jon Williams, and Ira Tabas
Arterioscler Thromb Vasc Biol. 2008;28:1723-1730; published online before print July 31 2008, doi:10.1161/ATVBAHA.108.173344
Abstract
|
Full Text
|
PDF
|
Data Supplement
Overexpression of Human ABCG1 Does Not Affect Atherosclerosis in Fat-Fed ApoE-Deficient Mice
Braydon Burgess, Kathryn Naus, Jeniffer Chan, Veronica Hirsch-Reinshagen, Gavin Tansley, Lisa Matzke, Benny Chan, Anna Wilkinson, Jianjia Fan, James Donkin, Danielle Balik, Tracie Tanaka, George Ou, Roger Dyer, Sheila Innis, Bruce McManus, Dieter Lütjohann, and Cheryl Wellington
Arterioscler Thromb Vasc Biol. 2008;28:1731-1737; published online before print July 3 2008, doi:10.1161/ATVBAHA.108.168542
Abstract
|
Full Text
|
PDF
|
Data Supplement
We developed transgenic mice expressing functional human ABCG1. Elevated ABCG1 levels did not affect plasma lipids, macrophage cholesterol efflux, atherosclerotic lesion area in apoE-/- mice, or levels of tissue cholesterol, cholesterol ester, phospholipids, or triglycerides. Transgenic ABCG1 was, however, associated with altered sterol intermediate levels in liver.
Alterations in Hepatic Metabolism in
fld
Mice Reveal a Role for Lipin 1 in Regulating VLDL-Triacylglyceride Secretion
Zhouji Chen, Matthew C. Gropler, Jin Norris, John C. Lawrence, Jr, Thurl E. Harris, and Brian N. Finck
Arterioscler Thromb Vasc Biol. 2008;28:1738-1744; published online before print July 31 2008, doi:10.1161/ATVBAHA.108.171538
Abstract
|
Full Text
|
PDF
|
Data Supplement
Absence of Hyperlipidemia in LDL Receptor-Deficient Mice Having Apolipoprotein B100 Without the Putative Receptor-Binding Sequences
Lance A. Johnson, Michael K. Altenburg, Rosemary L. Walzem, Lori T. Scanga, and Nobuyo Maeda
Arterioscler Thromb Vasc Biol. 2008;28:1745-1752; published online before print July 10 2008, doi:10.1161/ATVBAHA.108.169680
Abstract
|
Full Text
|
PDF
|
Data Supplement
Mice that lack the LDLR and ApoB editing enzyme (Ldlr-/- Apobec1-/-) accumulate LDL and develop severe atherosclerosis. Conversely, Ldlr-/- Apobec1-/- mice carrying Apob100-β with altered sequences in the putative LDLR-binding domains of apoB neither accumulate LDL nor develop atherosclerosis. This finding highlights a potential therapeutic target for patients with familial hypercholesterolemia.
Adenovirus-Mediated VEGF Gene Therapy Enhances Venous Thrombus Recanalization and Resolution
B. Modarai, J. Humphries, J.A. Gossage, M. Waltham, K.G. Burnand, G.S. Kanaganayagam, A. Afuwape, E. Paleolog, A. Smith, and A. Wadoodi
Arterioscler Thromb Vasc Biol. 2008;28:1753-1759; published online before print July 31 2008, doi:10.1161/ATVBAHA.108.170571
Abstract
|
Full Text
|
PDF
|
Data Supplement
Air Pollution Exposure Potentiates Hypertension Through Reactive Oxygen Species-Mediated Activation of Rho/ROCK
Qinghua Sun, Peibin Yue, Zhekang Ying, Arturo J. Cardounel, Robert D. Brook, Robert Devlin, Jing-Shiang Hwang, Jay L. Zweier, Lung Chi Chen, and Sanjay Rajagopalan
Arterioscler Thromb Vasc Biol. 2008;28:1760-1766; published online before print July 3 2008, doi:10.1161/ATVBAHA.108.166967
Abstract
|
Full Text
|
PDF
|
Data Supplement
Short-term exposure to ambient fine particles in an angiotensin II rat model exaggerates vasoconstriction and blood pressure through increases in vascular superoxide production and upregulation of the Rho/ROCK pathway.
A Novel Sartan Derivative With Very Low Angiotensin II Type 1 Receptor Affinity Protects the Kidney in Type 2 Diabetic Rats
Yuko Izuhara, Toshio Sada, Hiroaki Yanagisawa, Hiroyuki Koike, Shuichi Ohtomo, Takashi Dan, Sadayoshi Ito, Masaomi Nangaku, Charles van Ypersele de Strihou, and Toshio Miyata
Arterioscler Thromb Vasc Biol. 2008;28:1767-1773; published online before print July 24 2008, doi:10.1161/ATVBAHA.108.172841
Abstract
|
Full Text
|
PDF
|
Data Supplement
We have designed an ARB-derivative, R-147176, with a marked inhibitory effect on oxidative stress and advanced glycation but an extremely low affinity for the angiotensin II type 1 receptor. Despite a minimal blood pressure lowering effect, R-147176 provides significant renoprotection in three different experimental rat models with renal injury.
Hydrogen Peroxide Potentiates the EDHF Phenomenon by Promoting Endothelial Ca
2+
Mobilization
David H. Edwards, Yiwen Li, and Tudor M. Griffith
Arterioscler Thromb Vasc Biol. 2008;28:1774-1781; published online before print July 31 2008, doi:10.1161/ATVBAHA.108.172692
Abstract
|
Full Text
|
PDF
|
Data Supplement
Pharmacological analysis of relaxation and imaging of intracellular Ca2+ mobilization has shown that H2O2 can contribute to electrotonically-mediated EDHF-type relaxations by promoting Ca2+ release from stores and secondary opening of KCa channels. The thiol oxidant thimerosal mimics this previously unrecognized endothelial action of H2O2, consistent with sensitization of the InsP3 receptor.
Cell Biology/Signaling
VEGF Stimulates HDAC7 Phosphorylation and Cytoplasmic Accumulation Modulating Matrix Metalloproteinase Expression and Angiogenesis
Chang Hoon Ha, Bong Sook Jhun, Hung-Ying Kao, and Zheng-Gen Jin
Arterioscler Thromb Vasc Biol. 2008;28:1782-1788; published online before print July 10 2008, doi:10.1161/ATVBAHA.108.172528
Abstract
|
Full Text
|
PDF
|
Data Supplement
This study investigated the role of HDAC7 in VEGF signaling and angiogenesis. We found that VEGF stimulated PKD1-dependent HDAC7 phosphorylation and cytoplasmic accumulation in endothelial cells modulating expression of genes including MT1-MMP and MMP10. Furthermore, our results showed that PKD1-HDAC7 pathway regulates VEGF-induced endothelial cell migration, tube formation, and microvessel sprouting.
AMP-Activated Protein Kinase Promotes the Differentiation of Endothelial Progenitor Cells
Xiaoxia Li, Yingying Han, Wei Pang, Chenghong Li, Xuefen Xie, John Y.-J. Shyy, and Yi Zhu
Arterioscler Thromb Vasc Biol. 2008;28:1789-1795; published online before print July 3 2008, doi:10.1161/ATVBAHA.108.172452
Abstract
|
Full Text
|
PDF
|
Data Supplement
In human cord blood-derived EPCs, VEGF caused the phosphorylation of AMPK and eNOS, increased the expression of EC markers, and increased the angiogenesis of EPCs in vitro and in vivo. Similar effects were observed with lovastatin and AMPK agonist. The activation of AMPK provides a novel mechanism for EPC differentiation.
Transcriptional Activation of HIF-1 by ROR
and its Role in Hypoxia Signaling
Eun-Jin Kim, Young-Gun Yoo, Woo-Kyeom Yang, Young-Soun Lim, Tae-Young Na, In-Kyu Lee, and Mi-Ock Lee
Arterioscler Thromb Vasc Biol. 2008;28:1796-1802; published online before print July 24 2008, doi:10.1161/ATVBAHA.108.171546
Abstract
|
Full Text
|
PDF
|
Data Supplement
Protein Kinase G Phosphorylates Soluble Guanylyl Cyclase on Serine 64 and Inhibits Its Activity
Zongmin Zhou, Nazish Sayed, Anastasia Pyriochou, Charis Roussos, David Fulton, Annie Beuve, and Andreas Papapetropoulos
Arterioscler Thromb Vasc Biol. 2008;28:1803-1810; published online before print July 17 2008, doi:10.1161/ATVBAHA.108.165043
Abstract
|
Full Text
|
PDF
|
Data Supplement
12/15-Lipoxygenase Activity Increases the Degradation of Macrophage ATP-Binding Cassette Transporter G1
Melissa H. Nagelin, Suseela Srinivasan, Jianyi Lee, Jerry L. Nadler, and Catherine C. Hedrick
Arterioscler Thromb Vasc Biol. 2008;28:1811-1819; published online before print July 17 2008, doi:10.1161/ATVBAHA.108.167908
Abstract
|
Full Text
|
PDF
|
Data Supplement
ApoA-I Facilitates ABCA1 Recycle/Accumulation to Cell Surface by Inhibiting Its Intracellular Degradation and Increases HDL Generation
Rui Lu, Reijiro Arakawa, Chisato Ito-Osumi, Noriyuki Iwamoto, and Shinji Yokoyama
Arterioscler Thromb Vasc Biol. 2008;28:1820-1824; published online before print July 10 2008, doi:10.1161/ATVBAHA.108.169482
Abstract
|
Full Text
|
PDF
|
Data Supplement
Proteolytic Cleavage of High Mobility Group Box 1 Protein by Thrombin-Thrombomodulin Complexes
Takashi Ito, Ko-ichi Kawahara, Kohji Okamoto, Shingo Yamada, Minetsugu Yasuda, Hitoshi Imaizumi, Yuko Nawa, Xiaojie Meng, Binita Shrestha, Teruto Hashiguchi, and Ikuro Maruyama
Arterioscler Thromb Vasc Biol. 2008;28:1825-1830; published online before print July 3 2008, doi:10.1161/ATVBAHA.107.150631
Abstract
|
Full Text
|
PDF
|
Data Supplement
Thrombomodulin (TM), an endothelial thrombin-binding protein, can bind and sequester high mobility group box 1 (HMGB1). In the present study, we examined the end results of this binding, and found that thrombin-TM complexes degrade HMGB1 to a less proinflammatory form.
Clinical and Population Studies
Atorvastatin and Fenofibrate Have Comparable Effects on VLDL-Apolipoprotein C-III Kinetics in Men With the Metabolic Syndrome
Dick C. Chan, Gerald F. Watts, Esther M.M. Ooi, Juying Ji, Anthony G. Johnson, and P. Hugh R. Barrett
Arterioscler Thromb Vasc Biol. 2008;28:1831-1837; published online before print June 19 2008, doi:10.1161/ATVBAHA.108.170530
Abstract
|
Full Text
|
PDF
Gender-Specific Differences in the Kinetics of Nonfasting TRL, IDL, and LDL Apolipoprotein B-100 in Men and Premenopausal Women
Nirupa R. Matthan, Susan M. Jalbert, P. Hugh R. Barrett, Gregory G. Dolnikowski, Ernst J. Schaefer, and Alice H. Lichtenstein
Arterioscler Thromb Vasc Biol. 2008;28:1838-1843; published online before print July 24 2008, doi:10.1161/ATVBAHA.108.163931
Abstract
|
Full Text
|
PDF
To determine mechanism(s) responsible for the gender related differences in plasma lipoprotein concentrations, apolipoprotein kinetic studies were conducted. Compared to men, premenopausal women had lower TRL and LDL pool sizes as a consequence of higher TRL- and LDL-apoB-100 catabolic rates rather than changes in production rates.
Macrophages and Platelets Are the Major Source of Protease Nexin-1 in Human Atherosclerotic Plaque
Silvana Mansilla, Yacine Boulaftali, Laurence Venisse, Véronique Arocas, Olivier Meilhac, Jean-Baptiste Michel, Martine Jandrot-Perrus, and Marie-Christine Bouton
Arterioscler Thromb Vasc Biol. 2008;28:1844-1850; published online before print July 10 2008, doi:10.1161/ATVBAHA.108.171389
Abstract
|
Full Text
|
PDF
|
Data Supplement
Protease nexin-1 expression was analyzed in atherosclerotic carotid arteries. This serpin was highly expressed in the cap and in the necrotic core present in advanced lesions. Monocytes/macrophages and platelets are its main sources within the atherothrombotic lesion. Protease nexin-1 may thus have an impact in the development of atherosclerosis.
Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area
Jonathan H. Klein, Robert A. Hegele, Daniel G. Hackam, Marlys L. Koschinsky, Murray W. Huff, and J. David Spence
Arterioscler Thromb Vasc Biol. 2008;28:1851-1856; published online before print July 3 2008, doi:10.1161/ATVBAHA.108.169292
Abstract
|
Full Text
|
PDF
We investigated the effect of lipoprotein(a) and traditional risk factors on carotid ultrasound phenotypes. Lipoprotein(a) significantly predicted baseline stenosis and occlusion, but not baseline plaque area, and traditional risk factors predicted these 3 phenotypes differently, supporting the concept that stenosis and plaque are fundamentally different processes. Much of the effect of Lp(a) was related to occlusion, suggesting that its effect on atherogenesis is largely attributable to thrombosis and impaired fibrinolysis.
Longitudinal Change in Serum Gamma-Glutamyltransferase and Cardiovascular Disease Mortality: A Prospective Population-Based Study in 76 113 Austrian Adults
Alexander M. Strasak, Cecily C. Kelleher, Jochen Klenk, Larry J. Brant, Elfriede Ruttmann, Kilian Rapp, Hans Concin, Günter Diem, Karl P. Pfeiffer, Hanno Ulmer, and the VHM&PP Study Group
Arterioscler Thromb Vasc Biol. 2008;28:1857-1865; published online before print July 10 2008, doi:10.1161/ATVBAHA.108.170597
Abstract
|
Full Text
|
PDF
|
Data Supplement
We prospectively investigated the association of longitudinal GGT change with CVD mortality in 76 113 men and women. We found increasing GGT, even within its normal range, to significantly increase risk of fatal CVD, independently of baseline GGT and other classical CVD risk factors.
Effects of Six
APOA5
Variants, Identified in Patients With Severe Hypertriglyceridemia, on In Vitro Lipoprotein Lipase Activity and Receptor Binding
B. Dorfmeister, W.W. Zeng, A. Dichlberger, S.K. Nilsson, F.G. Schaap, J.A. Hubacek, M. Merkel, J.A. Cooper, A. Lookene, W. Putt, R. Whittall, P.J. Lee, L. Lins, N. Delsaux, M. Nierman, J.A. Kuivenhoven, J.J.P. Kastelein, M. Vrablik, G. Olivecrona, W.J. Schneider, J. Heeren, S.E. Humphries, and P.J. Talmud
Arterioscler Thromb Vasc Biol. 2008;28:1866-1871; published online before print July 17 2008, doi:10.1161/ATVBAHA.108.172866
Abstract
|
Full Text
|
PDF
|
Data Supplement
Sequencing APOA5 in 130 severe hypertriglyceridemic patients identified 3 novel heterozygous mutations E255G, G271C, and H321L. Together with the previously reported G185C, Q139X, Q148X, and novel {Delta}139 to 147 their impact in vitro, on LPL activity and receptor binding (LR8 and LRP1), was studied.
Mechanisms of the Factor V Leiden Paradox
K.J. van Stralen, C.J.M. Doggen, I.D. Bezemer, E.R. Pomp, T. Lisman, and F.R. Rosendaal
Arterioscler Thromb Vasc Biol. 2008;28:1872-1877; published online before print July 10 2008, doi:10.1161/ATVBAHA.108.169524
Abstract
|
Full Text
|
PDF
Carriers of the factor V Leiden mutation have substantial risk of deep venous thrombosis but a mild pulmonary embolism risk. Five potential mechanisms were explored; thrombus location, number of affected veins, time between provocation and diagnosis, in vitro coagulation time, and thrombus density. None of the mechanisms offered a clear explanation.
Letters to the Editor
Homocysteine Is Not So Paradoxical
Leslie M. Klevay
Arterioscler Thromb Vasc Biol. 2008;28:e160, doi:10.1161/ATVBAHA.108.172072
Extract
|
Full Text
|
PDF
Many Potential Explanations for the Homocysteine Paradox
Roman N. Rodionov and Steven R. Lentz
Arterioscler Thromb Vasc Biol. 2008;28:e161, doi:10.1161/ATVBAHA.108.172494
Extract
|
Full Text
|
PDF
Spotlight
TOC Spotlight File
Advertisement
ATVB Home
|
Subscriptions
|
Archives
|
Feedback
|
Authors
|
Help
|
AHA Journals Home
|
Search
Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.